// App-Quantinova.ai

5995 : How important is the anticoagulant strategy in primary percutaneous coronary intervention? Insights from the ATLANTIC study

Researchers

Presenter

  • W.J. Cantor

Principal Investigators

  • S.G. Goodman

  • A.W. Van' T Hof

  • G. Montalescot

Medical Centers

  • UHN - University of Toronto, Southlake Regional health Centre, Toronto, Canada

  • St Michaels Hospital, Respiratory Medicine, Toronto, Canada

  • Isala Clinics, cardiology, Zwolle, Netherlands

  • Sorbonne Université - Univ Paris 06 (UPMC), ACTION Study Group, INSERM UMR_S 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France

Locations

  • Canada

  • Netherlands

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Ticagrelor

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved